Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers.

Preskill C, Weidhaas JB.

Crit Rev Oncog. 2013;18(4):327-40. Review.

2.

MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Blitzblau RC, Weidhaas JB.

Mol Diagn Ther. 2010 Dec 1;14(6):335-42. doi: 10.2165/11587600-000000000-00000. Review.

PMID:
21275451
3.

SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer.

Salzman DW, Weidhaas JB.

Pharmacol Ther. 2013 Jan;137(1):55-63. doi: 10.1016/j.pharmthera.2012.08.016. Epub 2012 Sep 3. Review.

4.

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.

Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R.

J Cell Mol Med. 2012 Jan;16(1):8-21. doi: 10.1111/j.1582-4934.2011.01359.x. Review.

5.

Role of variations within microRNA-binding sites in cancer.

Landi D, Gemignani F, Landi S.

Mutagenesis. 2012 Mar;27(2):205-10. doi: 10.1093/mutage/ger055.

PMID:
22294768
6.

Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.

Ferracin M, Negrini M.

Expert Rev Mol Diagn. 2015;15(10):1369-81. doi: 10.1586/14737159.2015.1081058. Epub 2015 Sep 4. Review.

PMID:
26338209
7.

MicroRNA binding site polymorphisms as biomarkers of cancer risk.

Pelletier C, Weidhaas JB.

Expert Rev Mol Diagn. 2010 Sep;10(6):817-29. doi: 10.1586/erm.10.59.

8.

Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Chen Z, Xu L, Ye X, Shen S, Li Z, Niu X, Lu S.

PLoS One. 2013 Apr 16;8(4):e61008. doi: 10.1371/journal.pone.0061008. Print 2013. Review.

9.

Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.

Jiang Y, Chen J, Wu J, Hu Z, Qin Z, Liu X, Guan X, Wang Y, Han J, Jiang T, Jin G, Zhang M, Ma H, Wang S, Shen H.

Int J Cancer. 2013 Nov;133(9):2216-24. doi: 10.1002/ijc.28237. Epub 2013 Jul 11.

10.

Single-nucleotide polymorphisms among microRNA: big effects on cancer.

Song FJ, Chen KX.

Chin J Cancer. 2011 Jun;30(6):381-91. Review.

11.

Prognostic and predictive biomarkers: tools in personalized oncology.

Nalejska E, Mączyńska E, Lewandowska MA.

Mol Diagn Ther. 2014 Jun;18(3):273-84. doi: 10.1007/s40291-013-0077-9. Review.

12.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

13.

MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.

Dzikiewicz-Krawczyk A.

Crit Rev Oncol Hematol. 2015 Jan;93(1):1-17. doi: 10.1016/j.critrevonc.2014.08.006. Epub 2014 Sep 2. Review.

PMID:
25217091
14.

Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.

Huang SP, Lévesque E, Guillemette C, Yu CC, Huang CY, Lin VC, Chung IC, Chen LC, Laverdière I, Lacombe L, Fradet Y, Chang TY, Lee HZ, Juang SH, Bao BY.

Int J Cancer. 2014 Dec 1;135(11):2661-7. doi: 10.1002/ijc.28904. Epub 2014 Apr 22.

15.

Identification of diagnostic and prognostic biomarkers for cancer: Focusing on genetic variations in microRNA regulatory pathways (Review).

Guo Z, Shu Y, Zhou H, Zhang W.

Mol Med Rep. 2016 Mar;13(3):1943-52. doi: 10.3892/mmr.2016.4782. Epub 2016 Jan 14. Review.

PMID:
26782081
16.

MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.

Xu J, Tian S, Yin Z, Wu S, Liu L, Qian Y, Pei D, Gao W, Xu J, Yin Y, Liu P, Shu Y.

Lung Cancer. 2014 Sep;85(3):442-8. doi: 10.1016/j.lungcan.2014.06.010. Epub 2014 Jun 21.

PMID:
24997136
17.

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.

Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, Wang E, Wu M, Shen SH.

Nucleic Acids Res. 2007;35(13):4535-41. Epub 2007 Jun 21.

18.

MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?

Zarate R, Boni V, Bandres E, Garcia-Foncillas J.

Int J Mol Sci. 2012;13(1):840-65. doi: 10.3390/ijms13010840. Epub 2012 Jan 16. Review.

19.

miRNA profiling of cancer.

Di Leva G, Croce CM.

Curr Opin Genet Dev. 2013 Feb;23(1):3-11. doi: 10.1016/j.gde.2013.01.004. Epub 2013 Mar 4. Review.

20.

Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.

Schubert M, Spahn M, Kneitz S, Scholz CJ, Joniau S, Stroebel P, Riedmiller H, Kneitz B.

PLoS One. 2013 Jun 14;8(6):e65064. doi: 10.1371/journal.pone.0065064. Print 2013.

Supplemental Content

Support Center